Human organic cation transporter 2 (hOCT2; SLC22A2) is abundantly expressed in the kidney, and it plays important roles in the renal tubular secretion of cationic drugs. Although the transport characteristics of hOCT2 have been studied extensively, there is no information available for the transcriptional regulation of hOCT2. The present study was undertaken to identify the cis-element and trans-factor for basal expression of hOCT2. The transcription start site was located 385 nucleotides above the translation start site by using 5Ј-rapid amplification of cDNA ends. An approximately 4-kilobase fragment of the hOCT2 promoter region was isolated and the promoter activities were measured in the renal epithelial cell line LLC-PK 1 . A deletion analysis suggested that the region spanning Ϫ91 to Ϫ58 base pairs was essential for basal transcriptional activity. This region lacked a TATA-box but contained a CCAAT box and an E-box. Electrophoretic mobility shift assays showed that specific DNA/protein complexes were present in the E-box but not in the CCAAT box, and supershift assays revealed that upstream stimulatory factor 1 (USF-1), which belongs to the basic helix-loop-helix-leucine zipper family of transcription factors, bound to the E-box. Mutation of the E-box resulted in a decrease in hOCT2 promoter activity, and overexpression of USF-1 enhanced the hOCT2 promoter activity in a dose-dependent manner. This article reports the first characterization of the hOCT2 promoter and shows that USF-1 functions as a basal transcriptional regulator of the hOCT2 gene via the E-box.
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Numerous organic cations, including endogenous substances, xenobiotics, and metabolites, are excreted from the body. The kidney is critical for the elimination of organic cations, as is the liver, through active secretion via organic cation transport systems. The membrane potential-dependent organic cation transporters (OCTs) are located at the basolateral membrane of renal tubular cells, and they mediate the cellular uptake of cationic compounds from the blood (Koepsell, 1998; Inui et al., 2000; Jonker and Schinkel, 2004) . In the brush-border membranes, organic cations are excreted via H ϩ /organic cation antiport systems, which have been recently identified by Otsuka et al. (2005) and ourselves Terada et al., 2006) as the part of multidrug and toxin extrusion family.
Human (h)OCT2 and hOCT3, but not hOCT1, are expressed in the kidney, and hOCT2 was found to be the most abundant organic cation transporter in the kidney (Motohashi et al., 2002) . In addition, recent functional studies revealed that hOCT2 can transport several clinically important compounds such as creatinine , the biguanide agent metformin (Kimura et al., 2005) , and the anticancer agents cisplatin (Ciarimboli et al., 2005; Yonezawa et al., 2006) and oxaliplatin . Drug-drug interaction between cetirizine, a new histamine H 1 blocker, and pilsicainide, a new type of antiarrhythmic drug, was also demonstrated to be mediated by OCT2 in patients with renal insufficiency (Tsuruoka et al., 2006) . So far, the pharmacokinetic significance of hOCT2 has been mainly demonstrated by expression and functional transport analyses. Regarding the regulatory aspects, transport activity of hOCT2 is controlled by protein phosphorylation, which is caused by protein kinase C, protein kinase A, phosphatidylinositol 3-kinase, and calcium/calmodulin complex, and the substrate affinity, plasma membrane expression of hOCT2, or both were altered (Ç etinkaya et al., 2003; Biermann et al., 2006) . In contrast, transcriptional mechanisms of the hOCT2 gene have not been elucidated. Among the human organic ion transporter family, hepatic expression of human organic anion transporter 2 (Popowski et al., 2005) and hOCT1 (Saborowski et al., 2006) was shown to be transactivated by the hepatocyte nuclear factor 4␣ and suppressed by bile acids via small heterodimer partner. In the kidney, it has been recently demonstrated that the promoter activity of human organic anion transporter 3 is regulated by hepatocyte nuclear factor 1␣ (Kikuchi et al., 2006) , cAMP response element-binding protein-1, and activating transcription factor-1 (Ogasawara et al., 2006) .
In the present study, to fully understand the basic transcriptional regulation of hOCT2, we cloned the 5Ј-flanking region of the hOCT2 gene and identified the minimal region necessary for basal promoter activity. The present results provide direct evidence for the involvement of upstream stimulatory factor (USF)-1, which belongs to the basic helix-loophelix-leucine zipper family of transcription factors, bound to an E-box, in the regulation of basal promoter activity of hOCT2.
Materials and Methods

Materials.
Restriction enzymes were obtained from New England Biolabs (Beverly, MA). T4 kinase and T4 DNA ligase were purchased from Takara Bio (Otsu, Japan). [␥- 32 P]ATP was obtained from GE Healthcare (Little Chalfont, Buckinghamshire, UK). Antibodies used for supershift assays were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Determination of the Putative Transcription Start Site. The putative transcription start sites for hOCT2 were determined by 5Ј-rapid amplification of cDNA ends (5Ј-RACE) using Human Kidney Marathon-Ready cDNA (Clontech, Mountain View, CA) according to the manufacturer's instructions. The hOCT2 gene-specific primers for the RACE were designed and synthesized based on the genomic sequence. The 5Ј-RACE was performed with an adaptor primer 1, which came with the kit and a gene-specific primer of hOCT2. Nested PCR was performed with an adaptor primer 2 and a nested genespecific primer of hOCT2 (primer sequences are shown in Table 1 ). The PCR products were subcloned into the pGEM-T Easy Vector (Promega, Madison, WI) and sequenced using a multicapillary DNA sequencer RISA384 system (Shimadzu, Kyoto, Japan).
Genomic Cloning of the hOCT2 Promoter. The hOCT2 promoter was isolated from the human genomic DNA (Promega) by a PCR-based method using primers designed based on the human genomic DNA (Table 1 ). The PCR product was isolated by electrophoresis and subcloned into the firefly luciferase reporter vector, pGL3-Basic (Promega), at KpnI and MluI sites. This full-length reporter plasmid is hereafter referred to as Ϫ4261/ϩ23. The transcription factor-binding sites were predicted with TRANSFAC 6.0 software (http://www.gene-regulation.com/cgi-bin/pub/programs/ match/bin/match.cgi?), with a core similarity of 0.95 and a matrix similarity of 0.90.
Preparation of Deletion Reporter Constructs. The 5Ј-deleted constructs (Ϫ3654/ϩ23, Ϫ3140/ϩ23, Ϫ2479/ϩ23, Ϫ1291/ϩ23, Ϫ468/ ϩ23, and Ϫ411/ϩ23) were generated by digestion of the Ϫ4261/ϩ23 construct with KpnI and each of the following enzymes: EcoRI, BstXI, AatII, PstI, StuI, and NsiI, respectively. The ends were blunted with T4 DNA polymerase (Takara Bio) and then self-ligated. The other constructs were generated by PCR with primers containing a KpnI site and a MluI site (Table 1 ). The site-directed mutations in the putative E-box were introduced into the Ϫ91/ϩ23 construct with a QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA) with the primers listed in Table 1 . The nucleotide sequences of these deleted or mutated constructs were verified. Cloning of hUSF-1 cDNA. cDNA for hUSF-1 (accession no. NM_007122) was isolated from Human Kidney Marathon-Ready cDNA (Clontech). Primers are listed in Table 1 . The PCR product was subcloned into the expression vector pcDNA 3.1 (Invitrogen, Carlsbad, CA), and its sequence was verified.
Cell Culture and Luciferase Assay. The porcine kidney epithelial cell line LLC-PK 1 was obtained from American Type Culture Collection (ATCC CRL-1392; Manassas, VA). Cell culture, transfection, and the luciferase assay were performed as described previously .
Electrophoretic Mobility Shift Assay. Nuclear extract was prepared from LLC-PK 1 cells according to the method of Shimakura et al. (2005) . The probes listed in Table 1 were prepared by annealing complementary sense and antisense oligonucleotides, followed by end-labeling with [␥- 32 P]ATP using T4 polynucleotide kinase (Takara Bio) and purification through a Sephadex G-25 column (GE Healthcare). The binding mixture consisted of 10 g of LLC-PK 1 nuclear extract and unlabeled competitor probes in a buffer solution containing 120 mM KCl, 20 mM Tris-HCl, pH 7.5, 1.5 mM EDTA, 2 mM dithiothreitol, 10 mM NaF, 0.1 mM Na 3 VO 4 , 5% mM glycerol, 4% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate, and 2% protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan). After preincubation for 30 min, labeled probes (ϳ0.4 ng) were added, and the binding mixture was incubated for a further 30 min. For supershift assays, 1 g of USF-1 antibody (sc-8983X) or USF-2 antibody (sc-862X) was added 30 min before the addition of the labeled probe. The volume of the binding mixture was 20 l throughout the experiment. The DNA-protein complex was then separated on a 4% polyacrylamide gel at room temperature in 0.5ϫ Tris borate-EDTA buffer. The gels were dried and exposed to X-ray film for autoradiography.
Data Analysis. The results were expressed relative to the pGL3-Basic vector set, and they represent the means Ϯ S.E. of three replicates. Two or three experiments were conducted, and representative results are shown. Data were analyzed statically by the Student's t test or by the one-way analysis of variance followed by Dunnett's test.
Results
Determination of the Transcription Start Site for hOCT2 in Human Kidney Using 5-RACE. The transcription start site for hOCT2 in the human kidney was identified by 5Ј-RACE. The putative start site was determined using the longest RACE product. Sequencing of the amplified bands revealed that the terminal position of hOCT2 cDNA with the longest 5Ј-untranslated region was located 385 nucleotides above the translation start site, which is 243 base pairs upstream of the 5Ј-end of hOCT2 cDNA reported previously (Gorboulev et al., 1997) . So, the terminal position of hOCT2 cDNA with the longest 5Ј-untranslated region was numbered ϩ1 as the transcription start site in this study.
Isolation and Analysis of the 5-Flanking Region of the hOCT2 Gene. Based on the result of 5Ј-RACE, approximately 4 kilobases of the 5Ј-flanking region of the hOCT2 gene were isolated and subcloned into pGL3-Basic. Promoter activity was assessed in LLC-PK 1 cells, because this cell line has active organic cation transport systems (Saito et al., 1992) , and it shows promoter activity of rat OCT2 . To determine the minimal region required for basal activity of the promoter, a series of deletion constructs were transfected into LLC-PK 1 cells, and luciferase activity was measured (Fig. 1) . The longest reporter construct (Ϫ4261/ϩ23) had the same level of luciferase activity as the control vector pGL3-Basic. The level of luciferase activity gradually increased as the region spanning from Ϫ4261 to Ϫ91 was deleted, and the reporter construct (Ϫ91/ϩ23) had approximately 10-fold more luciferase activity than pGL3-Basic. In contrast, the constructs (Ϫ58/ϩ23, Ϫ40/ϩ23, and Ϫ18/ϩ23) exhibited little luciferase activity. These results suggested that the region between Ϫ91 and Ϫ58 contained positive cis-acting elements for efficient basal expression of the hOCT2 gene. Figure 2 shows a computational analysis of the Ϫ106/Ϫ58 region of the hOCT2 promoter. Using TRANS-FAC 6.0 (www.gene-regulation.com/), we found a putative CCAAT box (5Ј-CCAAA-3Ј) and E-box (5Ј-CACGTG-3Ј) in this region. The CCAAT box can be recognized by several transcription factors such as CCAAT/enhancer-binding proteins (Ramji and Foka, 2002) and nuclear factor-Y (Mantovani, 1999) , and the E-box is stimulated by USFs (Corre and Galibert, 2005) . These transcription factors were reported to help maintain the basal promoter activities of various genes.
Electrophoretic Mobility Shift Assay. To confirm which cis-element was involved in the basal promoter activity, EMSA was performed using nuclear extract from LLC-PK 1 cells and the hOCT2 probe (Ϫ101/Ϫ74), which contains both a CCAAT box and an E-box. At first, we tested the involvement of the CCAAT box. For a positive control of the EMSA for the CCAAT box, an oligonucleotide of the CCAAT box derived from the human pro-␣3(V) collagen gene (Nagato et al., 2004) was used. As shown in Fig. 3 , a specific DNAprotein complex was observed using the pro-␣3(V) collagen gene CCAAT box probe (lane 2). In the same buffer, the hOCT2 (Ϫ101/Ϫ74) probe formed a DNA-protein complex (lane 6), but this was prevented by the hOCT2 probe with mutCCAAT, which lacks a CCAAT box (lane 8). Furthermore, the consensus sequence for the CCAAT box did not prevent the formation of the complex (lane 9). These results suggested that nuclear extracts did not bind to the CCAAT box.
We then examined the contribution of the E-box. For a positive control, a oligonucleotide for the E-box derived from the heme oxygenase (HO)-1 promoter (Hock et al., 2004) was used. As shown in Fig. 4 , a specific DNA-protein complex was observed using the HO-1 gene E-box probe (lane 2), and this complex was supershifted using anti USF-1 antibody (lane 3). In these conditions, the hOCT2 probe also formed a DNAprotein complex (lane 6). The formation of this complex was completely prevented by the addition of an excess amount of unlabeled oligonucleotide for the hOCT2 probe (lane 7), hOCT2 mutCCAAT (lane 9), and the consensus sequence for the E-box (lane 10), but not by mutE-box lacking an E-box (lane 8). Furthermore, anti-USF-1 antibody, but not anti USF-2 antibody, was able to supershift the DNA-protein complex (lanes 11 and 12). These results indicated that USF-1 bound to the E-box of the hOCT2 promoter.
Mutagenesis of the E-box. To confirm the functional importance of the E-box, mutations were introduced into the Ϫ150/ϩ23 and Ϫ91/ϩ23 constructs and their promoter activities were examined. As shown in Fig. 5 , both constructs lost all luciferase activity compared with the wild type. These results suggest that the E-box is responsible for the basal promoter activity of hOCT2.
Transactivation of the Promoter Activity by Overexpression of USF-1. Finally, we investigated the effect of the overexpression of USF-1 on the promoter activity of hOCT2 (Fig. 6) . The Ϫ91/ϩ23 construct was cotransfected into LLC-PK 1 cells with the USF-1 expression vector. The promoter activity of hOCT2 showed a dose-dependent increase on the coexpression of USF-1, providing direct evidence that USF-1 enhanced the promoter activity.
Discussion
In the present study, we performed a functional promoter assay of hOCT2, and we obtained convincing evidence of the involvement of USF-1 bound to an E-box in the regulation of hOCT2 basal expression. This conclusion is supported by results of experiments involving EMSAs, mutagenesis of the E-box, and overexpression of USF-1. USF-1 was originally described as a transcription factor derived from HeLa nuclear extract that binds to an E-box of the adenovirus major late promoter (Sawadogo and Roeder, 1985) . Subsequent analysis revealed that this factor is involved in the basal transcriptional regulation of various genes, including the human angiotensinogen (Yanai et al., 1997) , HO-1 (Hock et al., 2004) , and prolyl-4-hydroxylase (I) (Chen et al., 2006) genes. Furthermore, USF acts not only as a classical upstream activator but also as a factor that interacts with initiator elements of a variety of core promoters, which can lead to markedly enhanced levels of basal transcription (Corre and Galibert, 2005) . The core E-box sequence CANNTG is usually conserved, with the two central sequence nucleotides (NN), in most cases, either GC or CG (Corre and Galibert, 2005) . Because the E-box of hOCT2 is Fig. 3 . EMSA of LLC-PK 1 nuclear proteins binding to the probes containing putative CCAAT box-binding elements. Nuclear extract from LLC-PK 1 cells was incubated with the 32 P-labeled oligonucleotide probes [pro 3␣(V) collagen gene probe and hOCT2 probe] alone (lanes 2 and 6) or in the presence of excess unlabeled WT oligonucleotide (lanes 4 and 7), mutated oligonucleotide (lanes 3 and 8), or pro 3␣(V) collagen gene oligonucleotide (lane 9). In lanes 1 and 5, nuclear extract was not added. CACGTG, a perfectly conserved consensus sequence, it is also reasonable that USF-1 binds to the E-box of the hOCT2 promoter region.
USF-1 is a key regulator of a number of gene regulatory networks, including the stress and immune responses, cell cycle and proliferation, and lipid and glucid metabolism (Corre and Galibert, 2005) . Familial combined hyperlipidemia, characterized by elevated levels of serum total cholesterol, triglycerides, or both, is associated with the USF-1 haplotype (Pajukanta et al., 2004) . Recently, it was reported that USF-1 gene polymorphisms are associated with increased sensitivity to antilipolytic insulin (Kantartzis et al., 2007) . In human kidney, the mRNA level of hOCT2 was highest of any of the OCT family (Motohashi et al., 2002) , suggesting that hOCT2 has a more important role in the transport of organic cations across the basolateral membrane than other members of the hOCT family in the proximal tubules. However, the expression pattern of renal drug transporters was reported to vary among patients (Terada and Inui, 2007) . This variation may be caused by single-nucleotide polymorphisms (SNPs) in the hOCT2 promoter region or USF-1 coding region.
Regulatory SNPs (rSNPs), which lie outside of the amino acid coding regions of genes, affect the regulation of gene expression. Recent research suggests that approximately 50% of genes have one or more common rSNPs associated with gene expression (Buckland, 2006) . For example, the uridine diphosphate glucuronosyltransferase UGT1A1*28 polymorphism, characterized by an extra TA repeat in the promoter region of the gene, is involved in the toxicity of irinotecan (Iyer et al., 2002) . Thiopurine S-methyltransferase, which is required to metabolize thiopurine, has a variable number tandem repeats in the 5Ј-flanking region involved in the gene expression (Alves et al., 2001) . In addition, it has been reported that a rSNP of SLC22A5 (OCTN2) affects the transcription of OCTN2, contributing to the pathogenesis of Crohn's disease (Peltekova et al., 2004) . A rSNP within the E-box core motif also modulates gene regulation. For example, a single base transition within the USF E-box consensus sequence of the thymidylate synthase gene, implicated in the metabolism of folate, prevents the USF complex from binding to its cognate sequence (Mandola et al., 2003) . It is unknown whether SNPs exist in the hOCT2 gene E-box, but it is possible that these SNPs affect the pharmacokinetics of cationic drugs.
USF-1 is a ubiquitously expressed transcription factor (Sirito et al., 1994) , but hOCT2 is mainly expressed in the kidney . The mechanism of this tissuespecific expression has not been clarified yet. The E-box of the hibernation-specific protein HP-27 is hypomethylated in the liver, but it is highly methylated in the kidney and heart, being involved in liver-specific expression (Fujii et al., 2006) . Kidney-specific transcription may be controlled by methylation of the E-box in the kidney or an unidentified kidneyspecific transcription factor.
In conclusion, the present results indicate that USF-1 functions as a basal transcriptional regulator of the hOCT2 gene, making this study the first to identify the cis-elements and trans-factors necessary for the regulation of hOCT2. These findings should serve as a basis for future investigations into the molecular regulation of the transport of organic cations and some pharmaceuticals in the human kidney. and Ϫ91/ϩ23 constructs (600 ng) were transiently expressed in LLC-PK 1 cells for luciferase assays. Firefly luciferase activity was normalized to Renilla luciferase activity. Data are reported as the relative -fold increase compared with pGL3-Basic vector and represent the means Ϯ S.E. of three replicates. ‫,ءء‬ P Ͻ 0.01, significantly different from WT. This figure is a representative one from three separate experiments. Fig. 6 . Effect of hUSF-1 overexpression on hOCT2 transcriptional activity. LLC-PK 1 cells were transiently transfected with 250 ng of the Ϫ91/ ϩ23 construct and 250, 500, and 1000 ng of the hUSF-1 expression vector. The total amount of transfected DNA was kept constant by adding empty vector. Data are reported as the relative -fold increase compared with no hUSF-1 and represent the means Ϯ S.E. of three replicates. ‫,ء‬ P Ͻ 0.05, significantly different from control (no USF-1). ‫,ءء‬ P Ͻ 0.01, significantly different from control. This figure is a representative one from three separate experiments. 
